4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-017786
CEO and CFO bought 29,000 shares at $9.13 ($264,770)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-24 | Purchase | +22,535 | $9.13 | $205,745 | 2,706,421 | D |
| Patel Snehal CEO and CFO | 2022-06-24 | Purchase | +6,465 | $9.13 | $59,025 | 2,712,886 | I |
| Open-market purchases · 29,000 sh · avg $9.13 · $264,770 | |||||||
Loading xslF345X03/ownership.xml…